INS and Alzheimer disease: Insulin signaling alterations have been reported in the different mouse models of AD, like the triple transgenic mouse model or the APP/PS1 transgenic model or the one induced by the intracerebroventricular (icv) injection of amyloid-β oligomers (reviewed in Lyra e Silva et al., 2019).